Index Investing News
Thursday, May 29, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Lilly, Scribe team up for neuro diseases CRISPR therapies

by Index Investing News
May 16, 2023
in Markets
Reading Time: 1 min read
A A
0
Home Markets
Share on FacebookShare on Twitter


rommma

Scribe Therapeutics is collaborating with Eli Lilly’s unit (NYSE:LLY) Prevail Therapeutics and granted rights to its CRISPR X-Editing (XE) technologies to develop in vivo therapies for neurological and neuromuscular diseases.

Under the agreement, Alameda, Calif.-based Scribe will get $75M consisting of an upfront payment and equity investment in the form of a convertible note, and is eligible to receive more than $1.5B in development and commercial milestone payments.

In addition, Prevail will pay research funding and royalties on future sales.

Privately held Scribe also has the right to opt-in to co-fund and share profits in the U.S. on one collaboration program, according to the company.

Scribe said its proprietary CRISPR by Design approach is the first of its kind and applies holistic engineering to transform bacterial immune systems into therapeutically relevant genome editing technologies. The company’s tools for in vivo genome editing directly modify genes in the body, providing benefits in safety, efficacy and delivery over existing methods.

“With the compelling in vivo proof-of-principle data we have generated in multiple disease areas, Scribe has validated our X-Editing technologies for industry-leading editing activity, specificity and deliverability,” said Scribe CEO Benjamin Oakes.

Scribe already has a collaboration with Biogen (NASDAQ:BIIB) to develop CRISPR-based therapies for amyotrophic lateral sclerosis (ALS).



Source link

Tags: CRISPRdiseasesLillyneuroScribeteamTherapies
ShareTweetShareShare
Previous Post

Web3 Firm Red Beard Ventures Closes $25M Funding Round With Animoca Labs, SuperRare

Next Post

NeoGames Acquisition Deal By Aristocrat Makes For A Nice Fit (NASDAQ:NGMS)

Related Posts

FL Infographic: Foot Locker slips to loss in Q1 2025; income down 5%

FL Infographic: Foot Locker slips to loss in Q1 2025; income down 5%

by Index Investing News
May 29, 2025
0

Foot Locker, Inc. (NYSE: FL), a number one footwear and attire retailer, reported a web loss for the primary quarter of...

China’s EV worth battle is heating up. What’s behind the large reductions?

China’s EV worth battle is heating up. What’s behind the large reductions?

by Index Investing News
May 29, 2025
0

Clients take a look at BYD electrical automobiles at an auto present in Yantai, in japanese China's Shandong province on...

Fed apprehensive it may face ‘troublesome tradeoffs’ if tariffs reaggravate inflation, minutes present

Fed apprehensive it may face ‘troublesome tradeoffs’ if tariffs reaggravate inflation, minutes present

by Index Investing News
May 29, 2025
0

Federal Reserve officers at their assembly earlier this month apprehensive that tariffs may worsen inflation and create a troublesome quandary...

Earnings Preview: Robust outcomes anticipated as Broadcom prepares for Q2 report

Earnings Preview: Robust outcomes anticipated as Broadcom prepares for Q2 report

by Index Investing News
May 28, 2025
0

Broadcom, Inc. (NASDAQ: AVGO), a market chief in semiconductor and infrastructure software program, shall be reporting second-quarter outcomes subsequent week...

Palantir groups up with Fannie Mae in AI push to smell out mortgage fraud

Palantir groups up with Fannie Mae in AI push to smell out mortgage fraud

by Index Investing News
May 29, 2025
0

Alex Karp, CEO of Palantir Applied sciences, speaks in the course of the Digital X occasion in Cologne, Germany, on...

Next Post
NeoGames Acquisition Deal By Aristocrat Makes For A Nice Fit (NASDAQ:NGMS)

NeoGames Acquisition Deal By Aristocrat Makes For A Nice Fit (NASDAQ:NGMS)

EU Council Approves Crypto Law

EU Council Approves Crypto Law

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

US-China tech trade wars reveal vulnerabilities on both sides

US-China tech trade wars reveal vulnerabilities on both sides

October 30, 2023
Notre Dame Vs. Ohio State

Notre Dame Vs. Ohio State

January 20, 2025
Monetary Providers Secretary Chairs Meet With Fintech Startups

Monetary Providers Secretary Chairs Meet With Fintech Startups

January 7, 2025
LRE on Tour – Might 20, 2022

LRE on Tour – Might 20, 2022

May 22, 2022
How you can tell which polls to trust — and why we need to fix our broken system

How you can tell which polls to trust — and why we need to fix our broken system

November 5, 2022
Top 5 Nickel Stocks to Invest in the Electric Vehicle Boom

Top 5 Nickel Stocks to Invest in the Electric Vehicle Boom

February 22, 2024
As housing costs soar, co-living makes a comeback

As housing costs soar, co-living makes a comeback

November 13, 2022
TLRY Infographic: Highlights of Tilray’s Q3 2025 monetary outcomes

TLRY Infographic: Highlights of Tilray’s Q3 2025 monetary outcomes

April 8, 2025
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In